Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
KST-6051 in KRAS mutant Non-small Cell Lung Cancer: NCT07458347 Clinical Landscape Report 2026
15 October 2026
NCT07458347 clinical landscape for KRAS mutant Non-small Cell Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
CB-Exo-A600 in Alzheimer Disease: NCT07457125 Clinical Landscape Report 2026
15 October 2026
NCT07457125 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
![[99mTc]Tc- HYNIC-FAPI in Lung Cancer: NCT07457541 Clinical Landscape Report 2026](https://synapse-static.patsnap.com/strapi-static/Blog_cover_13_1a4cebe3b5.jpg)
9 min read
[99mTc]Tc- HYNIC-FAPI in Lung Cancer: NCT07457541 Clinical Landscape Report 2026
15 October 2026
NCT07457541 clinical landscape for Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Linepemat in Young onset Parkinson disease: NCT07461220 Clinical Landscape Report 2026
15 October 2026
NCT07461220 clinical landscape for Young onset Parkinson disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
LW-1017 in Alzheimer Disease: ACTRN12626000328370 Clinical Landscape Report 2026
15 October 2026
ACTRN12626000328370 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Olaparib in Ovarian Epithelial Carcinoma: NCT07460180 Clinical Landscape Report 2026
15 October 2026
NCT07460180 clinical landscape for Ovarian Epithelial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Doxorubicin Hydrochloride in Ovarian Cancer: ISRCTN15843444 Clinical Landscape Report 2026
15 October 2026
ISRCTN15843444 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
18F-FCOB04 in Alzheimer Disease: NCT07470710 Clinical Landscape Report 2026
15 October 2026
NCT07470710 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
![[68Ga]FAPI-46 in Pancreatic adenocarcinoma: NCT07478523 Clinical Landscape Report 2026](https://synapse-static.patsnap.com/strapi-static/Blog_cover_03_d2c7dad0d6.jpg)
9 min read
[68Ga]FAPI-46 in Pancreatic adenocarcinoma: NCT07478523 Clinical Landscape Report 2026
15 October 2026
NCT07478523 clinical landscape for Pancreatic adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Gemcitabine in Pancreatic Ductal Adenocarcinoma: NCT07477418 Clinical Landscape Report 2026
15 October 2026
NCT07477418 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Clonal fetal MSCs(Shenzhen Geno-Immune Medical Institute) in Pulmonary Disease, Chronic Obstructive: NCT07477600 Clinical Landscape Report 2026
15 October 2026
NCT07477600 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
SHR-2524 in Unresectable Hepatocellular Carcinoma: NCT07478302 Clinical Landscape Report 2026
15 October 2026
NCT07478302 clinical landscape for Unresectable Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…